Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
national blog main
new york blog main
raleigh-durham blog main
5
×
san diego blog main
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
biotech
boston blog main
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
national top stories
new york top stories
raleigh-durham top stories
san diego top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
boston top stories
deals
alnylam pharmaceuticals
cancer
clinical trials
fda
imara
sanofi
10x genomics
abbvie
acc
acquisition
activist investor
aducanumab
What
help
5
×
bio
drug
roundup
deal
news
acquisitions
adding
adu
aims
alzheimer's
announced
approved
aren’t
bad
beats
bids
biogen
brain
cancer
case
ceo
collabs
company
complicated
covid
daniel
decisions
depression
developers
diagnostic
diagnostics
dire
disease
doses
drugs
expand
failed
fda
fight
Language
unset
Current search:
" raleigh-durham blog main "
×
help
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Veracyte Aims to Expand Diagnostics Reach With $50M NanoString Deal
@xconomy.com
4 years ago
Can Tiny Drug Doses (and One Woman’s Fortune) Fight the Most Vicious Cancer?
@xconomy.com
5 years ago
Bio Roundup: Sage Postpartum Help, Biogen Bids Adu, Heart Beats & More
@xconomy.com
5 years ago
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More
